Insider Trading March 17, 2026

D-Wave Director Executes $176K Stock Sale; Company Posts Q4 Revenue Shortfall

Director Rohit Ghai sold 10,000 shares under a prearranged plan as D-Wave reports revenue and EPS misses and an analyst trims its price target

By Maya Rios QBTS
D-Wave Director Executes $176K Stock Sale; Company Posts Q4 Revenue Shortfall
QBTS

Rohit Ghai, a director at D-Wave Quantum Inc. (QBTS), sold 10,000 shares on March 16, 2026, for $176,168 under a Rule 10b5-1 plan. The shares traded between $17.165 and $18.385, near the prevailing price of $17.47. D-Wave reported Q4 2025 revenue of $2.75 million and EPS of -$0.09, both missing analyst expectations, while Evercore ISI lowered its price target from $44 to $42 but left its Outperform rating intact. InvestingPro lists QBTS as overvalued on its Most Overvalued list and offers additional Pro Research coverage.

Key Points

  • Director Rohit Ghai sold 10,000 D-Wave shares on March 16, 2026, for $176,168 under a Rule 10b5-1 plan adopted June 13, 2025.
  • D-Wave reported Q4 2025 revenue of $2.75 million and EPS of -$0.09, both missing analyst expectations.
  • InvestingPro lists QBTS as overvalued; Evercore ISI reduced its price target from $44 to $42 but maintained an Outperform rating.

Director Rohit Ghai of D-Wave Quantum Inc. (NASDAQ: QBTS) completed an automated sale of 10,000 common shares on March 16, 2026, realizing proceeds of $176,168. The transaction occurred at prices within a band from $17.165 to $18.385, which is close to the company's quoted share price of $17.47 at the time of reporting.

The share disposition was carried out under a pre-existing Rule 10b5-1 trading arrangement that Ghai established on June 13, 2025. After the sale, Ghai retains direct ownership of 27,778 D-Wave shares, a total that includes 14,260 restricted stock units that have not yet vested.

Market performance metrics noted in company trading show the stock has fallen 33% year-to-date, while remaining 56% higher over the trailing 12 months.


Company financials and analyst action

In related corporate disclosures, D-Wave Systems Inc. published its fourth-quarter 2025 financial results, reporting revenue of $2.75 million. That figure represented a shortfall of 26.08% versus the consensus expectation of $3.72 million. The company also reported earnings per share of -$0.09, missing the anticipated -$0.06.

Separately, Evercore ISI revised its price target for D-Wave Quantum Inc. shares downward from $44 to $42 while retaining an Outperform recommendation. The firm described the adjustment as a reassessment of valuation tied to its forward earnings outlook.


Valuation context and research availability

Investment research platform InvestingPro classifies QBTS as currently overvalued based on its Fair Value analysis and includes the stock on its Most Overvalued list. The platform further indicates that a Pro Research Report covering QBTS and more than 1,400 other U.S. equities is available for investors seeking deeper analysis.


Key takeaways

  • Director Rohit Ghai executed an automatic sale of 10,000 shares on March 16, 2026, under a Rule 10b5-1 plan adopted June 13, 2025.
  • D-Wave reported Q4 2025 revenue of $2.75 million and EPS of -$0.09, missing consensus expectations.
  • InvestingPro flags QBTS as overvalued and Evercore ISI trimmed its price target from $44 to $42 while keeping an Outperform rating.

Contextual note

Where the public record is limited to the transaction details, plan adoption date, post-sale holdings, recent quarterly results, and third-party valuation and analyst actions, this report confines itself to those disclosed facts without further inference about motivations or future stock performance.

Risks

  • Valuation risk: InvestingPro identifies QBTS as overvalued, which may affect investor sentiment and demand for the stock.
  • Earnings and revenue shortfall risk: Q4 2025 revenue and EPS missed expectations, indicating performance risk that could influence market valuation and analyst outlooks.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026